Three BTTC Clinical Trials Open For Enrollment
This study’s primary objective is to determine if prophylactic administration of lacosamide reduces the risk of seizures in patients with a high-grade glioma. Newly diagnosed, post-operative patients are tested during the first year after tumor diagnosis.
This study will evaluate the occurrence of symptoms and their relations to disease progression, as well as the tolerance to treatment regimen. A Phase I-II trial everolimus and sorafenib in Patients with Recurrent High-Grade Gliomas.
This study will look at evaluating the occurrence of symptoms and their relations to disease progression, as well as the tolerance to the treatment regimen. Phase I/II Adaptive Randomized Trial of Bevacizumab versus Bevacizumab plus Vorinostat in Adults with Recurrent Glioblastoma.